ACB Stock Alert: The $50 Million Reason Aurora Cannabis Is Up Today

Source: Ralf Liebhold /

Aurora Cannabis (NASDAQ:ACB) stock is climbing higher on Thursday after completing its acquisition of MedReleaf Australia.

Aurora Cannabis used a wholly owned subsidiary to acquire the 90% stake in MedReleaf Australia that it didn’t already own. The deal is worth 50 million AUD ($32.4 million) with Aurora Cannabis paying 9.45 million AUD in cash and the remaining in ACB stock.

The acquisition of MedReleaf Australia gives Aurora Cannabis a firm footing in the medical cannabis market in Australia. This market is valued at 400 million AUD and is one of the largest medical marijuana markets outside of Canada.

Aurora Cannabis CEO Miguel Martin said the following about the deal:

“The acquisition of MedReleaf Australia represents a strategic milestone in Aurora’s global cannabis leadership, demonstrating our commitment to investing in markets that offer opportunities for sustainable and profitable growth […] We are excited to solidify our position in this rapidly growing market and the opportunity this transaction presents to us in accelerating our plans to deliver positive free cash flow in calendar 2024.”

Earnings Boost ACB Stock

Alongside the acquisition news comes the company’s earnings report for its fiscal third quarter. It posted revenue of $64.4 million during the quarter. This comes in above Wall Street’s estimate of $47.03 million. It’s also an improvement over the $61.1 million reported in the same period of the year prior.

ACB stock is up 1.5% as of Thursday morning.

Investors seeking out even more of the most recent stock market stories are in luck!

We have all of the hottest stock market news ready to go on Thursday! A few examples include what’s going on with shares of Disney (NYSE:DIS), Spirit Airlines (NYSE:SAVE) and Tenax Therapeutics (NASDAQ:TENX) stock today. We have all of that ready to go at the links below!

More Thursday Stock Market News

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that’s writers disclose this fact and warn readers of the risks. 

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Be the first to comment

Leave a Reply

Your email address will not be published.